Testing the pancreas involves several different approaches depending on what your doctor suspects. There’s no single “pancreas test.” Instead, clinicians choose from blood tests, stool samples, imaging scans, and specialized procedures based on whether they’re looking for inflammation, digestive problems, insulin issues, or cancer. Most pancreatic testing starts with simple blood work and becomes more involved only if initial results raise concerns.
Blood Tests for Pancreatic Inflammation
The most common first step is a blood test measuring two digestive enzymes: lipase and amylase. Your pancreas produces both to help break down food, and when the organ is inflamed or damaged, these enzymes leak into your bloodstream at elevated levels. A normal lipase level falls between 0 and 160 units per liter. A result three or more times higher than the upper limit of normal strongly suggests acute pancreatitis.
Doctors typically order lipase and amylase together because each can rise in different conditions. Lipase is more specific to the pancreas, while amylase can also be elevated from salivary gland problems. A formal diagnosis of acute pancreatitis requires at least two of three criteria: characteristic abdominal pain, enzyme levels at least three times the normal range, and imaging findings that confirm inflammation. Most people only need a blood draw and a physical exam to get a clear answer.
These tests require fasting for 8 to 12 hours beforehand. During that window, avoid eating, drinking anything besides water, chewing gum, or smoking. Let your provider know about any medications, vitamins, or supplements you take, since some can affect results.
Stool Tests for Digestive Function
Your pancreas produces enzymes that digest fat and protein. When it can’t make enough of these enzymes, a condition called exocrine pancreatic insufficiency (EPI), food passes through your system only partially digested. This causes greasy stools, bloating, weight loss, and nutrient deficiencies.
The standard test for this is a fecal elastase-1 test. You provide a stool sample, and the lab measures the concentration of elastase, a pancreatic enzyme that survives the trip through the digestive tract intact. A level above 500 micrograms per gram is considered normal. Below 200 micrograms per gram indicates the pancreas isn’t producing enough digestive enzymes. The range between 200 and 500 sits in a gray zone. Recent research suggests that EPI isn’t an all-or-nothing condition but a gradual decline, so levels in that middle range may still warrant treatment depending on your symptoms. Notably, symptoms of EPI typically don’t appear until enzyme output drops to less than 10% of normal levels, which means significant damage can exist before you notice anything wrong.
Testing Insulin Production
The pancreas also produces insulin through specialized cells called beta cells. When doctors need to evaluate how well this function is working, they measure C-peptide in your blood. C-peptide is a byproduct released in equal amounts alongside insulin, making it a reliable indicator of how much insulin your pancreas is actually producing.
A fasting C-peptide level below 0.6 ng/ml signals beta-cell failure, meaning the pancreas can no longer make adequate insulin. This test is particularly useful for distinguishing between type 1 and type 2 diabetes. In type 1 diabetes, the immune system destroys beta cells, so C-peptide levels are consistently low. In type 2 diabetes, C-peptide may be normal or even high early on (because the body is overproducing insulin to compensate for resistance), then drops as the disease progresses and beta cells burn out. The result directly influences treatment decisions, particularly whether someone needs insulin therapy.
Imaging: Seeing the Pancreas
Blood and stool tests reveal how the pancreas is functioning, but imaging shows its physical structure. The pancreas sits deep in the abdomen behind the stomach, which makes it harder to visualize than many other organs. Several imaging options exist, each with different strengths.
A CT scan with contrast is the most common first-line imaging test. It can reveal inflammation, fluid collections, cysts, and masses. For a more detailed look at the pancreatic duct (the tube that carries enzymes from the pancreas to the intestine), doctors turn to MRCP, or magnetic resonance cholangiopancreatography. MRCP is noninvasive, radiation-free, and well-tolerated. It produces 3D images of the pancreatic and bile ducts and can detect stones, strictures, congenital abnormalities, chronic pancreatitis, and tumors with accuracy comparable to more invasive alternatives.
The older, more invasive version is ERCP (endoscopic retrograde cholangiopancreatography). This involves sedation, threading a scope through the mouth to the small intestine, and injecting dye directly into the ducts. ERCP carries a 1% to 7% complication rate, including bleeding, infection, and even triggering pancreatitis itself, with about one in four complications being severe. Because of these risks, ERCP is now reserved mostly for situations where treatment can happen during the procedure, such as removing a stuck gallstone or placing a stent. For purely diagnostic purposes, MRCP has largely replaced it.
Endoscopic Ultrasound
Endoscopic ultrasound (EUS) places an ultrasound probe at the tip of a flexible scope, positioning it in the stomach or small intestine right next to the pancreas. This provides extremely detailed images and, critically, allows doctors to take a tissue sample at the same time. When a suspicious mass is found on CT or MRI, EUS-guided biopsy is typically the next step. The procedure has a diagnostic accuracy of about 88% for solid pancreatic masses, with 100% specificity, meaning that when it identifies cancer, it’s virtually always correct. If the first biopsy is inconclusive, a repeat attempt still achieves around 77% sensitivity.
Tumor Markers for Pancreatic Cancer
CA 19-9 is a blood marker often associated with pancreatic cancer. In people who already have symptoms, elevated CA 19-9 levels (above 37 U/mL) have a sensitivity of 79 to 81% and a specificity of 82 to 90% for detecting pancreatic cancer. Those numbers sound promising, but CA 19-9 is not useful for screening healthy people. In one study of nearly 71,000 asymptomatic individuals, over 1,000 had elevated CA 19-9, but only 4 of them actually had pancreatic cancer, giving a positive predictive value of just 0.9%. Many non-cancerous conditions, including bile duct blockages and other inflammations, can raise CA 19-9 levels. Doctors use it primarily to monitor treatment response in patients with a known diagnosis, not to screen for cancer in the general population.
Specialized Functional Tests
The secretin stimulation test directly measures how well the pancreas responds to a hormonal signal. A thin tube is passed through the nose into the stomach and down to the upper small intestine. The patient then receives an injection of secretin, a hormone that normally triggers the pancreas to release bicarbonate-rich fluid. Over about two hours, the fluid produced is collected and analyzed. Low bicarbonate concentration suggests the pancreas isn’t functioning properly. This test is considered highly accurate but is time-consuming and only available at specialized centers, so it’s typically reserved for cases where other tests have been inconclusive.
Genetic Testing for Hereditary Pancreatitis
When pancreatitis runs in families or strikes at an unusually young age, genetic testing can identify inherited mutations that predispose someone to the condition. The primary gene involved is PRSS1, which produces a digestive enzyme called trypsin. Certain gain-of-function mutations in PRSS1 cause trypsin to activate prematurely inside the pancreas, essentially making the organ start digesting itself. Several modifier genes can worsen this effect, including SPINK1 (which normally inhibits premature trypsin), CFTR (the gene linked to cystic fibrosis), and CTRC. Genetic testing panels typically screen all of these simultaneously.
Identifying a hereditary cause doesn’t change treatment for an acute episode, but it affects long-term management. People with hereditary pancreatitis face a significantly higher lifetime risk of pancreatic cancer, so knowing your genetic status helps guide how aggressively you and your doctors should monitor the organ over time.
What to Expect From the Testing Process
For most people, pancreatic testing starts with blood work and possibly a stool sample. If those point to a problem, imaging comes next, usually a CT scan or MRCP. Biopsies via endoscopic ultrasound happen only when a mass needs to be identified. The whole diagnostic process can take anywhere from a single office visit (for straightforward acute pancreatitis) to several weeks if multiple tests are needed to pin down a chronic or complex condition.
If you’re preparing for pancreatic blood tests, plan to fast for 8 to 12 hours and bring a list of your current medications. For imaging tests involving contrast dye, you may be asked about kidney function and allergies beforehand. Endoscopic procedures require sedation, so you’ll need someone to drive you home and should expect to take the rest of the day off.